Search alternatives:
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
641
-
642
Image_5_miR-144-5p and miR-451a Inhibit the Growth of Cholangiocarcinoma Cells Through Decreasing the Expression of ST8SIA4.tif
Published 2021“…This study aimed to investigate the action mechanism of miR-144-5p and miR-451a in cholangiocarcinoma. We found that miR-144-5p and miR-451a were significantly decreased in cholangiocarcinoma patient samples compared to the adjacent normal bile duct samples. …”
-
643
Suppression of APN/CD13 expression by siRNA induced a marked decrease in migratory potential of ES-2 cells
Published 2011“…</p><p>Published online 27 Jul 2007</p><p>PMCID:PMC2000898.</p><p></p> A; Western blot analysis showed a decrease in APN/CD13 expression after siRNA transfection. …”
-
644
(R)-albuterol decreases cytokine protein levels in activated T cells
Published 2011“…</p><p></p> (R)-albuterol, (S)-albuterol or racemic albuterol (R + S) at a dose (10M) were added to T (EL-4) cells pre-activated with mitogens Concanavalin A (Con A, 5 μg/ml) and phorbol myristate acetate (PMA, 100 ng/ml) (CP). …”
-
645
(R)-albuterol decreases cytokine levels in activated murine splenocytes
Published 2011“…</p><p></p> (R)-albuterol (R), (S)-albuterol (S) or racemic albuterol (R + S) at a dose (10M) were added to murine splenocytes pre-activated with mitogens Concanavalin A (Con A, 5 μg/ml) and phorbol myristate acetate (PMA, 100 ng/ml) (CP), (Fig 3 A, B). …”
-
646
-
647
-
648
-
649
-
650
-
651
Bonding, Ion Mobility, and Rate-Limiting Steps in Deintercalation Reactions with ThCr<sub>2</sub>Si<sub>2</sub>-type KNi<sub>2</sub>Se<sub>2</sub>
Published 2012“…Here, we study the nature of metal–metal bonding in the ThCr<sub>2</sub>Si<sub>2</sub> structure type by probing the rate-limiting steps in the oxidative deintercalation of KNi<sub>2</sub>Se<sub>2</sub>. …”
-
652
Bonding, Ion Mobility, and Rate-Limiting Steps in Deintercalation Reactions with ThCr<sub>2</sub>Si<sub>2</sub>-type KNi<sub>2</sub>Se<sub>2</sub>
Published 2012“…Here, we study the nature of metal–metal bonding in the ThCr<sub>2</sub>Si<sub>2</sub> structure type by probing the rate-limiting steps in the oxidative deintercalation of KNi<sub>2</sub>Se<sub>2</sub>. …”
-
653
Bonding, Ion Mobility, and Rate-Limiting Steps in Deintercalation Reactions with ThCr<sub>2</sub>Si<sub>2</sub>-type KNi<sub>2</sub>Se<sub>2</sub>
Published 2012“…Here, we study the nature of metal–metal bonding in the ThCr<sub>2</sub>Si<sub>2</sub> structure type by probing the rate-limiting steps in the oxidative deintercalation of KNi<sub>2</sub>Se<sub>2</sub>. …”
-
654
Bonding, Ion Mobility, and Rate-Limiting Steps in Deintercalation Reactions with ThCr<sub>2</sub>Si<sub>2</sub>-type KNi<sub>2</sub>Se<sub>2</sub>
Published 2012“…Here, we study the nature of metal–metal bonding in the ThCr<sub>2</sub>Si<sub>2</sub> structure type by probing the rate-limiting steps in the oxidative deintercalation of KNi<sub>2</sub>Se<sub>2</sub>. …”
-
655
-
656
-
657
Hepatic irradiation decreases the proportion of DX5<sup>–</sup>TRAIL<sup>+</sup> lrNK cells for up to two months.
Published 2018“…NK cells were divided into DX5<sup>–</sup>TRAIL<sup>+</sup> lrNK cells and DX5<sup>+</sup>TRAIL<sup>−</sup> cNK cells. …”
-
658
-
659
-
660
DataSheet2_Treatment of wild-type mice with 2,3-butanediol, a urinary biomarker of Fmo5−/− mice, decreases plasma cholesterol and epididymal fat deposition.pdf
Published 2022“…Our results indicate a microbial contribution to the phenotypic characteristic of Fmo5<sup>−/−</sup> mice of decreased plasma cholesterol and identify 2,3-butanediol as a potential agent for lowering plasma cholesterol.…”